This webinar will provide an overview of the regulatory processes and standards that the U.S. Food and Drug Administration (FDA) has applied to the COVID-19 vaccines being used to fight the pandemic. More specifically, Dr. Nancy Pire-Smerkanich will discuss how the FDA is assessing the benefits and risks of the vaccine candidates that have received Emergency Use Authorization, how this impacts future approvals, and the U.S. Department of Health and Human Services' (HHS) vaccine distribution process.

Dr. Nancy Pire-Smerkanich is an Assistant Professor of Regulatory and Quality Sciences at the USC School of Pharmacy. She has over 35 years of experience in the biopharmaceutical industry where she participates in the regulatory and clinical aspects of new drug and biologic product development.

Zoom link: https://usc.zoom.us/j/92798152995
Meeting ID: 92798152995
Call in: (669) 900-6833